Table 3.
Comparison of Change in Visual Function by Operated Eye, Pre-Operative BCVA, and Type of Cataract
Questionnaire/Group | Mean Change (± SD) | Median Change (IQR) | p-value |
---|---|---|---|
VF-14 | |||
1st eye (n = 22) | 14.83 ± 12.53 | 0.448a | |
2nd eye (n = 26) | 17.90 ± 14.89 | ||
IVI | |||
1st eye | −10 (13.5) | 0.541b | |
2nd eye | −6.5 (12.5) | ||
VF-14 | |||
6/6 or better (n = 15) | 17.57 ± 12.77 | 0.721a | |
6/7.5 or 6/9 (n = 33) | 16.01 ± 14.41 | ||
IVI | |||
6/6 or better | −7 (12) | 0.824b | |
6/7.5 or 6/9 | −9 (15.5) | ||
VF-14 | |||
PSCC (n = 14) | 20.50 ± 13.56 | 0.201a | |
No PSCC (n = 34) | 14.85 ± 13.76 | ||
IVI | |||
PSCC | −16 (17.25) | 0.040b | |
No PSCC | −6 (9.5) |
Notes: aIndependent samples t-test and bMann–Whitney U-test comparing change in visual function from baseline to 4 months between 1st eye patients and 2nd eye patients, between patients with pre-operative best corrected visual acuity of 6/6 or better vs patients with pre-operative best corrected visual acuity of 6/7.5 or 6/9 in the operated eye, and between patients with posterior sub-capsular cataract vs patients with cortical and/or nuclear cataract only.
Abbreviations: BCVA, best corrected visual acuity; SD, standard deviation; IQR, inter-quartile range; VF-14, Visual Function Index; IVI, Impact of Visual Impairment questionnaire; PSCC, posterior sub-capsular cataract.